More articles from Current Drug Therapy
- Antiobesity drug therapy: An individualized and comprehensive approach
As part of a comprehensive plan, these drugs can provide lasting obesity control and additional health benefits, including decreased cardiovascular risk.
- Prescribing testosterone and DHEA: The role of androgens in women
Androgens play an important physiologic role and can promote sexual health.
- The role of SGLT-2 inhibitors in managing type 2 diabetes
These drugs improve glycemic control and offer cardiovascular and metabolic benefits.
- CGRP antagonists for decreasing migraine frequency: New options, long overdue
CGRP drugs are an exciting frontier, but migraine management is still a combination of lifestyle changes plus treatment.
- ACE inhibitors and ARBs: Managing potassium and renal function
Concern about hyperkalemia and a decline in renal function has led to underuse of these drugs.
- Diabetes management: Beyond hemoglobin A1c
Other factors include cardiovascular benefit, weight control, hypoglycemia risk, and cost.
- Hydroxychloroquine: An old drug with new relevance
This antimalarial drug is now approved to treat discoid lupus, systemic lupus erythematosus, and rheumatoid arthritis.
- Pharmacotherapy for obesity: What you need to know
Weight-loss drugs are not magic pills, but they can help when used along with diet, exercise, and other lifestyle changes.
- Dual antiplatelet therapy for acute coronary syndromes: How long to continue?
After drug-eluting stent placement, at least 12 months of dual antiplatelet therapy is recommended. Would longer be better?
- Ceftaroline fosamil: A super-cephalosporin?
Ceftaroline fosamil is the first beta-lactam with clinically useful activity against methicillin-resistant Staphylococcus aureus.